£76.24

Biomarkers in Renal Disease (Nova B Iomedical)

Renal

Price data last checked 22 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£76 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 69 days · 69 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 69 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £79 (61 days, 88.4%)

Price range: £76 - £79

Price levels: 3 different prices over 69 days

Description

Advances in long-term improvement and outcomes of patients with kidney disease will require the use of novel biomarkers to identify patients at high risk for kidney disease and to diagnose kidney disease early for effective treatment. A biomarker is a substance found in the blood, body fluids or tissues that provides a measure of normal biological or pathological processes or response to pharmacological compounds or drugs. There are a wide variety of biomarkers including but not limited to mRNA, proteins and peptides, and lipid molecules. In AKI, important pathophysiological processes such as inflammation, apoptotic and necrotic cell death and, tubule regeneration may be reflected in blood or urine. An array of candidate markers along with clinical information in long-term clinical studies with appropriate analytical methodologies will likely provide prognostic information. Despite well-known limitations, currently the most widely used biomarkers for the early diagnosis of CKD and AKI are proteinuria, serum creatinine and blood urea nitrogen. Most clinicians are aware that serum creatinine and blood urea nitrogen are poor biomarkers due to inherent characteristics of these molecules and handling by the kidney. Creatinine is secreted and urea nitrogen is reabsorbed by the renal tubules. Many endogenous substances interfere in the assay for creatinine. Serum creatinine and urea appear late after acute kidney injury and the serum levels in part depend on the generation (large or small body mass). Acute kidney injury is a non steady state condition thus serum creatinine and urea nitrogen will lag behind kidney injury. For these reasons new biomarkers are imperative. With knowledge of these limitations in use of current biomarkers and the lack of progress in reducing the mortality and morbidity from kidney disease, there has been a great surge of interest in identifying novel biomarkers with a particular emphasis on the early diagnosis of kidney disease. A variety of methods have been employed including transcriptomics, proteomics, gene arrays and lipidomics. Currently, candidate biomarkers have been found in different disorders and have been tested in humans and many candidate biomarkers have yet to be identified. Most studies to date are preliminary and require validation in large multicentre studies followed by commercial assay development validation and testing. This new book outlines the rapid advances made in the field of biomarker development for kidney disease in which a variety of novel molecules have been identified and studied in humans.

Key Features

New

Mint Condition

Dispatch same day for order received before 12 noon

Guaranteed packaging

No quibbles returns

Product Specifications

Format: hardcover
ASIN: 1604561130
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Renal
Domain: Amazon UK
Release Date: 12 July 2008
Listed Since: 16 November 2007

Barcode

No barcode data available

Biomarkers in Renal Disease (Nova B Iomedical)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Biomarkers of Kidney Disease

Biomarkers in Kidney Disease (Biomarkers in Disease: Methods, Discoveries and Applications)

Kidney Research: Experimental Protocols: 1397 (Methods in Molecular Biology, 1397)

Hydrogen Sulfide in Kidney Diseases: A Novel Pharmacotherapy

Humana Urinary Biomarkers: Methods and Protocols - 2292

Brenner y Rector. El riñón + ExpertConsult (10ª ed.), (Volum 1 and 2)

Comorbidities in Chronic Kidney Disease - Medical Textbook

New Trends in Biomarkers and Disease Research - Bentham Science

International Yearbook of Nephrology 1991: 3

Renal Failure: Prevention, Causes & Treatment (Renal and Urologic Disorders)

Evidence-Based Nephrology, 2 Volume Set (Evidence-Based Medicine)

Kidney Research: Experimental Protocols: 1397 (Methods in Molecular Biology, 1397)

Nephrology and Hypertension Board Review

Springer Persistent Renal-Genitourinary Disorders Book 17

Informing Clinical Practice in Nephrology: The Role of RCTs

The Total Synthesis of Natural Products, Volumes 10 and 11, 2 Volume Set: Volume Ten and Volume Eleven: 12

Long-Term Hemodialysis

Renal Pathology Express - An Essential Companion for a Nephrologist

Handbook of Nutrition and the Kidney (Lippincott Williams and Wilkins Handbook Series)

Retransplantation: Proceedings of the 29th Conference on Transplantation and Clinical Immunology, 9–11 June, 1997: 29

Renal and Electrolyte Disorders

Einzelfunktionen der Niere beim akuten Nierenversagen: 1423 (Forschungsberichte des Landes Nordrhein-Westfalen, 1423)

NEUTROPHIL GELATINASE ASSOCIATED LIPOCA: from Laboratory to Clinical Utility (Renal and Urologic Disorders)

Retransplantation Springer - 29th Conference Proceedings